For comments, suggestions
Created with Raphaël 2.1.0 21.12.2016 Formal examination (assignment of filing date) 27.06.2017 Filing of an application 20.07.2017 Preliminary and substantive examination 31.10.2017 Publication of the decision of grant (B1) 30.04.2018 Completion of the opposition filing period 31.05.2018 Issuance of patent (C1) 21.12.2021 Valid until 31.07.2023 Publication of the decision of forfeiture, the term of re-establishment has expired

Patent lapsed


(11)Number of the document4519
(21)Number of the applicationa 2017 0068
(22)Filing date of the application2016.12.21
 Date of filing the request for examination (de fond) 07.08.2017
(71)Name(s) of applicant(s), code of the countryINSTITUTUL DE CHIMIE, MD;
(72)Name(s) of inventor(s), code of the countryMACAEV Fliur, MD; ZVEAGHINTEVA Marina, MD; STANGACI Eugenia, MD; POGREBNOI Serghei, MD; DUCA Gheorghe, MD;
(73)Name(s) of owner(s), code of the countryINSTITUTUL DE CHIMIE AL ACADEMIEI DE STIINTE A MOLDOVEI, MD;
(54)Title of the inventionUse of (Z)-4,4-dimethyl-1-(4-nitrophenyl)-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-one as antituberculous agent
(62)Earlier divided applicationa 2016 0145, 2016.12.21
(13)Kind-of-document code
C1, BOPI 05/2018
B1, BOPI 10/2017
(51)International Patent Classification A61K 31/4196 (2006.01); A61K 31/33 (2006.01); A61P 31/06 (2006.01); C07D 249/08 (2006.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2017.10.31
(47)Date of issuance of patent2018.05.31
 Substantive examiner(s)JOVMIR Tudor, SPATARU Leonid
 Payment for maintenance up to the date2021.12.21
 Date of patent termination2021.12.21
 Date of publication of the termination of patent, with the right of restoration2022.07.31
 Date of publication of the termination of patent, without the right of restoration2023.07.31
Up
/inventions/details/a 2017 0068